Biosynex SA reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was EUR 142.2 million compared to EUR 225.2 million a year ago. Net income was EUR 30.6 million compared to EUR 70.5 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.1 EUR | +1.23% | +1.49% | -50.90% |
05-13 | Biosynex: Oren Bitton appointed Chief Operating Officer | CF |
04-30 | Biosynex SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-50.90% | 47.89M | |
-4.92% | 12.27B | |
-5.82% | 7.99B | |
+5.43% | 5.69B | |
+26.16% | 5.42B | |
-9.58% | 4.13B | |
-59.63% | 2.7B | |
+8.44% | 2.6B | |
-3.70% | 2.38B | |
+21.00% | 2.1B |
- Stock Market
- Equities
- ALBIO Stock
- News Biosynex
- Biosynex SA Reports Earnings Results for the Half Year Ended June 30, 2022